Semmax Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Semmax Financial Advisors's PFE Position: Q2 2025 in Review
Semmax Financial Advisors increased its Pfizer (PFE) stake by 3.4% in Q2 2025, buying an estimated $91.3K and bringing the position to 118,076 shares worth $2.95M. The position accounts for 0.76% of the portfolio, ranked #51.
Semmax Financial Advisors first reported a position in PFE in Q4 2018 and has held it in 25 quarters since. The position peaked at $5.44M in Q3 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Semmax Financial Advisors held 118,076 shares of Pfizer worth $2.95M as of Q2 2025.
- Semmax Financial Advisors bought 3,916 Pfizer shares in Q2 2025, an estimated $91.3K.
- Pfizer made up 0.76% of Semmax Financial Advisors's portfolio in Q2 2025, its #51 holding.
- Semmax Financial Advisors first reported a position in Pfizer in Q4 2018 and has held it in 25 quarters since.
- Semmax Financial Advisors's Pfizer position peaked at $5.44M in Q3 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.